Back to Results
First PageMeta Content
Demography / Long-acting reversible contraceptive / IUD with copper / IUD with progestogen / Emergency contraception / Intrauterine device / Birth control / Implanon / Depo-Provera / Hormonal contraception / Medicine / Human reproduction


Microsoft Word - LARCstatementSHFPA151013.docx
Add to Reading List

Document Date: 2013-10-27 18:31:29

Open Document

File Size: 153,48 KB

Share Result on Facebook

City

Washington / DC / Melbourne / Sydney / /

Company

Sage LC / SH&FPA Medical Reference Group / Fleming / Tang LC / Grulich AE / Bayer / FPPs / Cummins / O&Gs / Edelman AB / National Academies Press / /

Country

Jordan / United States / Australia / United Kingdom / New Zealand / /

Facility

The American College of Gynaecologists / Institute of Medicine / /

IndustryTerm

healthcare practitioners / intrauterine device / insurance rebate / levonorgestrel-releasing intrauterine device / reproductive and sexual health services / public health services / intrauterine devices / /

Organization

Faculty of Sexual & Reproductive Healthcare / World Health Organisation / Task Force / World Health Organization / Society for Adolescent Medicine / Committee on Comparative Effectiveness Research Prioritization / Jacobs Institute of Women / Faculty of Sexual and Reproductive Healthcare / Institute of Medicine / The American College / National Collaborating Centre for Women / Clinical Effectiveness Unit / Medicare / /

Person

Van Vliet / Arch Gynecol Obstet / /

Position

Singer / Peterson HB / nurse / representative / Harper / /

Product

medroxyprogesterone acetate / Implanon / While DMPA injections / /

ProvinceOrState

Western Australia / South Australia / /

PublishedMedium

The Medical journal / The New England journal / /

RadioStation

Lalla AM / Kaunitz AM / Smith AM / /

Region

South Australia / New England / Western Australia / /

Technology

pharmacokinetics / GPS / pharmacodynamics / /

URL

http /

SocialTag